Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis

• Main Authors: Caiwei Yu (Author), Hui Liu (Author), Chunjing Guo (Author), Qiang Chen (Author), Yanguo Su (Author), Huimin Guo (Author), Xiaoya Hou (Author), Feng Zhao (Author), Huaying Fan (Author), Hui Xu (Author), Yan Zhao (Author), Xiaofeng Mu (Author), Guohua Wang (Author), Haiyu Xu (Author), Daquan Chen (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rheumatoid arthritis (RA) is an ordinarily occurring autoimmune disease with systemic inflammatory. Targeted drug delivery systems have many successful applications in the treatment of rheumatoid arthritis. In order to develop nanoparticles for targeted delivery of Celastrol (Cel) to rheumatoid arth...